Pay in 4 interest-free payments of $6.37 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
References: (1) Graf M, Baumann JB, Girard J, Tobler HJ, Schoenenberger GA
doi: 10.1095/biolreprod.115.137539 164 SunZLiPWangXLaiSQiuHChenZet al
In the Phase IV study, semaglutide will be evaluated for its effects on improving depressive symptoms over 26 weeks in patients with major depressive disorder who also have overweight or obesity (Vinberg, 2026, ID NCT07136714)
The clinical trials needed to establish safety and efficacy in this population are still underway
US$ 24.92
US$ 28.58
.jpg)
US$ 23.76
US$ 20.10
US$ 20.64
US$ 27.73
US$ 24.42
